Trials / Recruiting
RecruitingNCT05645081
Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
PREDICT-EV; the Association of Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 360 (estimated)
- Sponsor
- Cwm Taf University Health Board (NHS) · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Annually 100,000 strokes occur, placing stroke as the largest cause of disability in the UK. 90% of strokes are preventable, leading to national focus on programmes including "The National Stroke Programme" to act on preventing, treating, and improving post-stroke care. Importantly, over 25% of ischaemic stroke sufferers have previously had a Transient Ischaemic Attack (TIA), which presents the biggest concern for TIA patients. There are no measures which reliably identify TIA patients most likely to suffer a stroke. Novel biomarkers for predicting stroke are key to addressing this problem. The PREDICT-EV study aims to screen 300 TIA patients and follow them over 12-months. The investigators will determine if a novel biomarker we've identified to increase thrombotic risk (endothelial derived extracellular vesicles) and the resulting increased prothrombin time is associated with patients at highest risk of stroke.
Conditions
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2026-09-01
- Completion
- 2027-09-01
- First posted
- 2022-12-09
- Last updated
- 2024-08-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05645081. Inclusion in this directory is not an endorsement.